Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Clinical trial NCT05527821 · UNKNOWN

Trial details

NCT number: NCT05527821
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Advanced Solid Tumors Biliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer

Start date: 2022-09-30
Primary completion: 2024-09-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.